Preclinical Investigation of the Functional Effects of Memantine and Memantine Combined with Galantamine or Donepezil
Open Access
- 22 November 2006
- journal article
- research article
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 32 (6) , 1284-1294
- https://doi.org/10.1038/sj.npp.1301259
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Galantamine Activates Muscle-Type Nicotinic Acetylcholine Receptors without Binding to the Acetylcholine-Binding SiteJournal of Neuroscience, 2005
- Co-administration of memantine has no effect on the in vitro or ex vivo determined acetylcholinesterase inhibition of rivastigmine in the rat brainNeuropharmacology, 2004
- Nefiracetam and physostigmine: separate and combined effects on learning in older rabbitsNeurobiology of Aging, 2004
- Memantine Treatment in Patients With Moderate to Severe Alzheimer Disease Already Receiving DonepezilJAMA, 2004
- Paradigm shift in neuroprotective drug development: clinically tolerated NMDA receptor inhibition by memantineCell Death & Differentiation, 2003
- Eyeblink Classical Conditioning and Awareness RevisitedPsychological Science, 1997
- Early acquisition, but not retention, of the classically conditioned eyeblink response is N-methyl-D-aspartate (NMDA) receptor dependent.Behavioral Neuroscience, 1996
- Evaluation of Cognition‐enhancing Drugs: Utility of the Model System of Eyeblink Classical ConditioningCNS Drug Reviews, 1995
- Disruption of classical conditioning in patients with Alzheimer's diseaseNeurobiology of Aging, 1991
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976